Global Lymphedema Diagnostics Market by Technology (Bioimpedance Analysis, Computed Tomography, Lymphoscintigraphy), Disease (Cancer, Cardiovascular Disease, Inflammatory Diseases), End User - Forecast 2024-2030- Product Image

Sale

Global Lymphedema Diagnostics Market by Technology (Bioimpedance Analysis, Computed Tomography, Lymphoscintigraphy), Disease (Cancer, Cardiovascular Disease, Inflammatory Diseases), End User - Forecast 2024-2030

Report
195 Pages
March 2024
Region: Global
360iResearch™
ID: 4896737

UP TO €846EUR$875USD£727GBP OFF until Dec 31^st 2024

The Lymphedema Diagnostics Market size was estimated at USD 32.48 million in 2023, USD 35.46 million in 2024, and is expected to grow at a CAGR of 9.26% to reach USD 60.40 million by 2030.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Lymphedema Diagnostics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Lymphedema Diagnostics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Lymphedema Diagnostics Market, highlighting leading vendors and their innovative profiles. These include Canon, Inc., Curadel, LLC, Esaote SPA, Essity Medical Solutions, Fluoptics, General Electric Company, ImpediMed Inc., Julius Zorn GmbH, Mindray Medical International, Ltd., Mitaka USA, Inc., Neusoft Corporation, Shimadzu Corporation, Siemens Healthineers AG, Stryker Corporation, and United Imaging Healthcare Co., Ltd.

Market Segmentation & Coverage

This research report categorizes the Lymphedema Diagnostics Market to forecast the revenues and analyze trends in each of the following sub-markets:

Technology
- Bioimpedance Analysis
- Computed Tomography
- Lymphoscintigraphy
- Magnetic Resonance Imaging
- Near-Infrared Fluorescence Imaging
- Ultrasound Imaging
- X-Ray Lymphography
Disease
- Cancer
- Cardiovascular Disease
- Inflammatory Diseases
End User
- Diagnostic Centers
- Hospitals
- Research & Academic Institutes

Region
- Americas
  - Argentina
  - Brazil
  - Canada
  - Mexico
  - United States
    - California
    - Florida
    - Illinois
    - New York
    - Ohio
    - Pennsylvania
    - Texas
- Asia-Pacific
  - Australia
  - China
  - India
  - Indonesia
  - Japan
  - Malaysia
  - Philippines
  - Singapore
  - South Korea
  - Taiwan
  - Thailand
  - Vietnam
- Europe, Middle East & Africa
  - Denmark
  - Egypt
  - Finland
  - France
  - Germany
  - Israel
  - Italy
  - Netherlands
  - Nigeria
  - Norway
  - Poland
  - Qatar
  - Russia
  - Saudi Arabia
  - South Africa
  - Spain
  - Sweden
  - Switzerland
  - Turkey
  - United Arab Emirates
  - United Kingdom

The report offers valuable insights on the following aspects:

Market Penetration: It presents comprehensive information on the market provided by key players.
Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

What is the market size and forecast of the Lymphedema Diagnostics Market?
Which products, segments, applications, and areas should one consider investing in over the forecast period in the Lymphedema Diagnostics Market?
What are the technology trends and regulatory frameworks in the Lymphedema Diagnostics Market?
What is the market share of the leading vendors in the Lymphedema Diagnostics Market?
Which modes and strategic moves are suitable for entering the Lymphedema Diagnostics Market?

Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report

Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

With the purchase of this report at the Multi-user License or greater level, you will have access to one hour with an expert analyst who will help you link key findings in the report to the business issues you're addressing. This will need to be used within three months of purchase.

This report also includes a complimentary Excel file with data from the report for purchasers at the Site License or greater level.

1. Preface

1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology

2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

4.1. Introduction
4.2. Lymphedema Diagnostics Market, by Region

5. Market Insights

5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing prevalence of lymphedema
5.1.1.2. Increasing incidences of cardiovascular diseases and cancer
5.1.1.3. Rising adoption of technologically advanced three dimensional imaging systems
5.1.2. Restraints
5.1.2.1. High Cost of diagnostic imaging systems
5.1.3. Opportunities
5.1.3.1. Advancement in technology such as new diagnostic modalities
5.1.3.2. Increasing investment and funds in research and developmen
5.1.4. Challenges
5.1.4.1. Difficulties in early stage diagnosis of lymphedema
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.4. Cumulative Impact of High Inflation
5.5. Porter’s Five Forces Analysis
5.5.1. Threat of New Entrants
5.5.2. Threat of Substitutes
5.5.3. Bargaining Power of Customers
5.5.4. Bargaining Power of Suppliers
5.5.5. Industry Rivalry
5.6. Value Chain & Critical Path Analysis
5.7. Regulatory Framework

6. Lymphedema Diagnostics Market, by Technology

6.1. Introduction
6.2. Bioimpedance Analysis
6.3. Computed Tomography
6.4. Lymphoscintigraphy
6.5. Magnetic Resonance Imaging
6.6. Near-Infrared Fluorescence Imaging
6.7. Ultrasound Imaging
6.8. X-Ray Lymphography

7. Lymphedema Diagnostics Market, by Disease

7.1. Introduction
7.2. Cancer
7.3. Cardiovascular Disease
7.4. Inflammatory Diseases

8. Lymphedema Diagnostics Market, by End User

8.1. Introduction
8.2. Diagnostic Centers
8.3. Hospitals
8.4. Research & Academic Institutes

9. Americas Lymphedema Diagnostics Market

9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Lymphedema Diagnostics Market

10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Lymphedema Diagnostics Market

11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape

12.1. FPNV Positioning Matrix
12.2. Market Share Analysis, By Key Player
12.3. Competitive Scenario Analysis, By Key Player

13. Competitive Portfolio

13.1. Key Company Profiles
13.1.1. Canon, Inc.
13.1.2. Curadel, LLC
13.1.3. Esaote SPA
13.1.4. Essity Medical Solutions
13.1.5. Fluoptics
13.1.6. General Electric Company
13.1.7. ImpediMed Inc.
13.1.8. Julius Zorn GmbH
13.1.9. Mindray Medical International, Ltd.
13.1.10. Mitaka USA, Inc.
13.1.11. Neusoft Corporation
13.1.12. Shimadzu Corporation
13.1.13. Siemens Healthineers AG
13.1.14. Stryker Corporation
13.1.15. United Imaging Healthcare Co., Ltd.
13.2. Key Product Portfolio

14. Appendix

14.1. Discussion Guide
14.2. License & Pricing

List of Figures

FIGURE 1. LYMPHEDEMA DIAGNOSTICS MARKET RESEARCH PROCESS
FIGURE 2. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, 2023 VS 2030
FIGURE 3. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 4. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2030 (%)
FIGURE 5. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 6. LYMPHEDEMA DIAGNOSTICS MARKET DYNAMICS
FIGURE 7. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
FIGURE 8. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 9. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2030 (%)
FIGURE 10. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 11. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2030 (%)
FIGURE 12. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 13. AMERICAS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 14. AMERICAS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 15. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
FIGURE 16. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 17. ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 18. ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
FIGURE 21. LYMPHEDEMA DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
FIGURE 22. LYMPHEDEMA DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023

List of Tables

TABLE 1. LYMPHEDEMA DIAGNOSTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
TABLE 3. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 6. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY BIOIMPEDANCE ANALYSIS, BY REGION, 2018-2030 (USD MILLION)
TABLE 7. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COMPUTED TOMOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY LYMPHOSCINTIGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY MAGNETIC RESONANCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY NEAR-INFRARED FLUORESCENCE IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY ULTRASOUND IMAGING, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY X-RAY LYMPHOGRAPHY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 14. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY CARDIOVASCULAR DISEASE, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY INFLAMMATORY DISEASES, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 18. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. AMERICAS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 22. AMERICAS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 23. AMERICAS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 24. AMERICAS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 25. ARGENTINA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 26. ARGENTINA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 27. ARGENTINA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 28. BRAZIL LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 29. BRAZIL LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 30. BRAZIL LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 31. CANADA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 32. CANADA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 33. CANADA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 34. MEXICO LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 35. MEXICO LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 36. MEXICO LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 37. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 38. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 39. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 40. UNITED STATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 41. ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 42. ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 43. ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 44. ASIA-PACIFIC LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 45. AUSTRALIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 46. AUSTRALIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 47. AUSTRALIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 48. CHINA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 49. CHINA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 50. CHINA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 51. INDIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 52. INDIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 53. INDIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 54. INDONESIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 55. INDONESIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 56. INDONESIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 57. JAPAN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 58. JAPAN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 59. JAPAN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 60. MALAYSIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 61. MALAYSIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 62. MALAYSIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 63. PHILIPPINES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 64. PHILIPPINES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 65. PHILIPPINES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 66. SINGAPORE LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 67. SINGAPORE LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 68. SINGAPORE LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 69. SOUTH KOREA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 70. SOUTH KOREA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 71. SOUTH KOREA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. TAIWAN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 73. TAIWAN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 74. TAIWAN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 75. THAILAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 76. THAILAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 77. THAILAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 78. VIETNAM LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 79. VIETNAM LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 80. VIETNAM LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 81. EUROPE, MIDDLE EAST & AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 82. EUROPE, MIDDLE EAST & AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 83. EUROPE, MIDDLE EAST & AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 84. EUROPE, MIDDLE EAST & AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 85. DENMARK LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 86. DENMARK LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 87. DENMARK LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. EGYPT LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 89. EGYPT LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 90. EGYPT LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 91. FINLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 92. FINLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 93. FINLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 94. FRANCE LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 95. FRANCE LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 96. FRANCE LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 97. GERMANY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 98. GERMANY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 99. GERMANY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 100. ISRAEL LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 101. ISRAEL LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 102. ISRAEL LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 103. ITALY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 104. ITALY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 105. ITALY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 106. NETHERLANDS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 107. NETHERLANDS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 108. NETHERLANDS LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 109. NIGERIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 110. NIGERIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 111. NIGERIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 112. NORWAY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 113. NORWAY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 114. NORWAY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 115. POLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 116. POLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 117. POLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 118. QATAR LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 119. QATAR LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 120. QATAR LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. RUSSIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 124. SAUDI ARABIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 125. SAUDI ARABIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 126. SAUDI ARABIA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 127. SOUTH AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 128. SOUTH AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 129. SOUTH AFRICA LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 130. SPAIN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 131. SPAIN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 132. SPAIN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 133. SWEDEN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 134. SWEDEN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 135. SWEDEN LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 136. SWITZERLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 137. SWITZERLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 138. SWITZERLAND LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 139. TURKEY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 140. TURKEY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 141. TURKEY LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 142. UNITED ARAB EMIRATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 143. UNITED ARAB EMIRATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 144. UNITED ARAB EMIRATES LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. UNITED KINGDOM LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
TABLE 146. UNITED KINGDOM LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY DISEASE, 2018-2030 (USD MILLION)
TABLE 147. UNITED KINGDOM LYMPHEDEMA DIAGNOSTICS MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 148. LYMPHEDEMA DIAGNOSTICS MARKET, FPNV POSITIONING MATRIX, 2023
TABLE 149. LYMPHEDEMA DIAGNOSTICS MARKET SHARE, BY KEY PLAYER, 2023
TABLE 150. LYMPHEDEMA DIAGNOSTICS MARKET LICENSE & PRICING

Companies Mentioned

Canon, Inc.
Curadel, LLC
Esaote SPA
Essity Medical Solutions
Fluoptics
General Electric Company
ImpediMed Inc.
Julius Zorn GmbH
Mindray Medical International, Ltd.
Mitaka USA, Inc.
Neusoft Corporation
Shimadzu Corporation
Siemens Healthineers AG
Stryker Corporation
United Imaging Healthcare Co., Ltd.

Methodology

LOADING...

Table Information

Report Attribute	Details
No. of Pages	195
Published	March 2024
Forecast Period	2024 - 2030
Estimated Market Value ( USD ) in 2024	$ 35.46 Million
Forecasted Market Value ( USD ) by 2030	$ 60.4 Million
Compound Annual Growth Rate	9.2%
Regions Covered	Global
No. of Companies Mentioned	15

PURCHASE OPTIONS

Single User License Online Access - 1 Year

Single User License PDF, Excel And Online Access - 1 Year

1 - 5 User License PDF, Excel And Online Access - 1 Year

Site License PDF, Excel And Online Access - 1 Year

Enterprise License PDF, Excel And Online Access - 1 Year

need a quote ?

License	Format	Properties	Price
SINGLE USER LICENSE Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€3262EUR$3,374USD£2,802GBP €3624EUR$3,749USD£3,113GBP
SINGLE USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a single user license, allowing one user access to the product.	€4132EUR$4,274USD£3,549GBP €4591EUR$4,749USD£3,944GBP
1 - 5 USER LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a 1-5 user license, allowing up to five users have access to the product.	€5002EUR$5,174USD£4,297GBP €5558EUR$5,749USD£4,774GBP
SITE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is a site license, allowing all users within a given geographical location of your organization access to the product.	€5872EUR$6,074USD£5,044GBP €6525EUR$6,749USD£5,605GBP
ENTERPRISE LICENSE PDF, Excel and Online Access - 1 Year	The product can be accessed through a secure website. Username and password will be sent via email. The access period is one year.	This is an enterprise license, allowing all employees within your organization access to the product.	€7613EUR$7,874USD£6,539GBP €8458EUR$8,749USD£7,265GBP

FPNV Positioning Matrix

Market Share Analysis

Key Company Profiles

Market Segmentation & Coverage

The report offers valuable insights on the following aspects:

The report addresses key questions such as:

Table of Contents

Companies Mentioned

Methodology

Table Information

Related Topics

Related Reports

Lymphedema Diagnostics Market Report: Trends, Forecast and Competitive Analysis to 2030

Lymphedema Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2018-2028F

Lymphedema Diagnostics - Global Strategic Business Report

Global Lymphedema Diagnostics Market (2023-2028) Competitive Analysis, Impact of Covid-19, Impact of Economic Slowdown & Impending Recession, Ansoff Analysis

2023 Global Forecast for Lymphedema Diagnostics Market (2024-2029 Outlook) - High Tech & Emerging Markets Report

About the Lymphedema Diagnostics Market